ASO Author Reflections: Role of SOX9 Transcription Factor in Pancreatic Neoplasms.
作者信息
Turner Kevin, Gnerlich Jennifer L
机构信息
Department of Surgery, University of Cincinnati, Cincinnati, OH, USA.
Department of Surgery, Louisiana State University Health Sciences Center, New Orleans, LA, USA.
出版信息
Ann Surg Oncol. 2019 Dec;26(Suppl 3):567-568. doi: 10.1245/s10434-019-07154-9. Epub 2019 Jan 24.
PMID:30680476
Abstract
摘要
相似文献
1
ASO Author Reflections: Role of SOX9 Transcription Factor in Pancreatic Neoplasms.
Ann Surg Oncol. 2019 Dec;26(Suppl 3):567-568. doi: 10.1245/s10434-019-07154-9. Epub 2019 Jan 24.
2
NFATc1 Links EGFR Signaling to Induction of Sox9 Transcription and Acinar-Ductal Transdifferentiation in the Pancreas.NFATc1将表皮生长因子受体（EGFR）信号传导与胰腺中Sox9转录的诱导及腺泡-导管转分化联系起来。
Gastroenterology. 2015 May;148(5):1024-1034.e9. doi: 10.1053/j.gastro.2015.01.033. Epub 2015 Jan 23.
3
Sox9-dependent acinar-to-ductal reprogramming is critical for pancreatic intraepithelial neoplasia formation.Sox9依赖性腺泡-导管重编程对于胰腺上皮内瘤变的形成至关重要。
Gastroenterology. 2013 Oct;145(4):904-7. doi: 10.1053/j.gastro.2013.08.028. Epub 2013 Aug 21.
4
ASO Author Reflections: Tumor-Infiltrating Platelets Predict Postsurgical Survival in Patients with Pancreatic Ductal Adenocarcinoma.ASO作者反思：肿瘤浸润血小板可预测胰腺导管腺癌患者术后生存率
Ann Surg Oncol. 2018 Dec;25(13):3994-3995. doi: 10.1245/s10434-018-6737-6. Epub 2018 Oct 12.
5
ASO Author Reflections: Health Disparities in Pancreatic Cancer.美国骨科学会作者反思：胰腺癌中的健康差异
Ann Surg Oncol. 2018 Dec;25(Suppl 3):824-825. doi: 10.1245/s10434-018-6961-0. Epub 2018 Oct 30.
6
ASO Author Reflections: Tumor-Infiltrating NETs are New Biomarkers to Predict Postsurgical Survival for Patients with Pancreatic Ductal Adenocarcinoma.美国骨矿研究学会作者反思：肿瘤浸润性神经内分泌肿瘤是预测胰腺导管腺癌患者术后生存的新生物标志物。
Ann Surg Oncol. 2019 Dec;26(Suppl 3):571-572. doi: 10.1245/s10434-019-07169-2. Epub 2019 Feb 1.
7
ASO Author Reflections: Re-Excision for Ductal Carcinoma In Situ: Who Is at Risk?《美国外科医师学会（ASO）作者反思：导管原位癌再次切除：谁有风险？》
Ann Surg Oncol. 2021 Mar;28(3):1398-1399. doi: 10.1245/s10434-020-09141-x. Epub 2020 Sep 18.
8
ASO Author Reflections: Do Distinct Patterns of Recurrence Impact the Prognosis of Patients With Resected Pancreatic Ductal Adenocarcinoma?ASO作者反思：复发的不同模式会影响接受手术切除的胰腺导管腺癌患者的预后吗？
Ann Surg Oncol. 2018 Dec;25(Suppl 3):806-807. doi: 10.1245/s10434-018-6820-z. Epub 2018 Oct 8.
9
ASO Author Reflections: Even in Pancreatic Cancer, not all N Diseases are Created Equal.ASO作者反思：即使在胰腺癌中，并非所有N类疾病都是一样的。
Ann Surg Oncol. 2018 Dec;25(Suppl 3):804-805. doi: 10.1245/s10434-018-6813-y. Epub 2018 Oct 3.
10
Evaluation of SOX9 expression in pancreatic ductal adenocarcinoma and intraductal papillary mucinous neoplasm.评估胰腺导管腺癌和导管内乳头状黏液性肿瘤中 SOX9 的表达。
Pancreas. 2013 Apr;42(3):488-93. doi: 10.1097/MPA.0b013e318269d281.
Zotero 插件